T. Rowe Price Associates
DCTH icon

T. Rowe Price Associates’s Delcath Systems DCTH Stock Holding History

T. Rowe Price Associates’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200K Buy
21,479
+5,403
+34% +$52.3K ﹤0.01% 2843
2025
Q4 		$163K Hold
16,076
– – ﹤0.01% 2856
2025
Q3 		$173K Buy
16,076
+998
+7% +$11.1K ﹤0.01% 2824
2025
Q2 		$206K Buy
+15,078
New +$210K ﹤0.01% 2702

Other funds holding DCTH

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAC
Private Wealth Advisors (California) Fresno, California $356M AUM 26.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

T. Rowe Price Associates's DCTH Position: Q1 2026 in Review

T. Rowe Price Associates increased its Delcath Systems (DCTH) stake by 34% in Q1 2026, buying an estimated $52.3K and bringing the position to 21,479 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

T. Rowe Price Associates first reported a position in DCTH in Q2 2025 and has held it in 4 quarters since. The position peaked at $206K in Q2 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • T. Rowe Price Associates held 21,479 shares of Delcath Systems worth $200K as of Q1 2026.
  • T. Rowe Price Associates bought 5,403 Delcath Systems shares in Q1 2026, an estimated $52.3K.
  • Delcath Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2843 holding.
  • T. Rowe Price Associates first reported a position in Delcath Systems in Q2 2025 and has held it in 4 quarters since.
  • T. Rowe Price Associates's Delcath Systems position peaked at $206K in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.